Literature DB >> 6601472

Autoantibodies and their clinical significance in a black vitiligo population.

P E Grimes, R M Halder, C Jones, S G Chakrabarti, J Enterline, H R Minus, J A Kenney.   

Abstract

The frequency of autoantibodies was determined in 70 black vitiligo patients and controls. Both groups were screened for antithyroid, antinuclear, antigastric parietal cell, anti-smooth muscle cell, and antimitochondrial autoantibodies. The significance of autoantibodies was determined in vitiligo patients by correlating their presence or absence with various clinical features of the patients. The overall frequencies of autoimmune and endocrine diseases were also assessed in vitiligo patients, controls, and their respective families. Vitiligo patients had an increased frequency of antithyroid antibodies and an increased frequency of autoimmune and/or endocrine diseases. These diseases included, especially, hyperthyroidism, hypothyroidism, and alopecia areata. Autoantibody-positive vitiligo patients had an increased frequency of first- and second-degree relatives having autoimmune and/or endocrine diseases. These findings tend to support an autoimmune cause of vitiligo in black patients.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6601472

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


  7 in total

Review 1.  New treatment modalities for vitiligo: focus on topical immunomodulators.

Authors:  Kresimir Kostovic; Aida Pasic
Journal:  Drugs       Date:  2005       Impact factor: 9.546

2.  A Retrospective Study of 3,000 Indian Patients with Vitiligo Treated with Phototherapy or Topical Monotherapy.

Authors:  Jagdish Sakhiya; Dhruv Sakhiya; Neha Virmani; Trusha Gajjar; Jitesh Kaklotar; Ravi Khambhati; Feral Daruwala; Nimish Dudhatra
Journal:  J Clin Aesthet Dermatol       Date:  2021-02-01

3.  Autoimmune diseases in vitiligo: do anti-nuclear antibodies decrease thyroid volume?

Authors:  G Zettinig; A Tanew; G Fischer; W Mayr; R Dudczak; M Weissel
Journal:  Clin Exp Immunol       Date:  2003-02       Impact factor: 4.330

4.  The Prevalence of Thyroid Disorders in Patients With Vitiligo: A Systematic Review and Meta-Analysis.

Authors:  Jinping Yuan; Chong Sun; Shibin Jiang; Yansong Lu; Yuhui Zhang; Xing-Hua Gao; Yan Wu; Hong-Duo Chen
Journal:  Front Endocrinol (Lausanne)       Date:  2019-01-15       Impact factor: 5.555

5.  Isolation of a Melanoblast Stimulator from Dimocarpus longan, Its Structural Modification, and Structure-Activity Relationships for Vitiligo.

Authors:  Jae-Won Song; Sunju Choi; Gayeong Kim; Hyang Bok Lee; P Sankara Rao; Jeonghyun Shin; Eun Ki Kim; Dong-Gyu Cho
Journal:  Molecules       Date:  2022-03-25       Impact factor: 4.411

6.  Anti-thyroid peroxidase antibody and vitiligo: a controlled study.

Authors:  Maryam Daneshpazhooh; Mahtab Mostofizadeh G; Javad Behjati; Maryam Akhyani; Reza Mahmoud Robati
Journal:  BMC Dermatol       Date:  2006-03-10

7.  Human immunodeficiency virus-associated vitiligo: expression of autoimmunity with immunodeficiency?

Authors:  M Duvic; R Rapini; W K Hoots; P W Mansell
Journal:  J Am Acad Dermatol       Date:  1987-10       Impact factor: 11.527

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.